Early gout flare recurrence in patients who initiate urate-lowering therapy (ULT) during an acute disease flare is predicted by C-reactive protein (CRP) levels and use of prophylaxis, according to a Dutch study. Gout flare recurrence occurred in 48% of patients within three months of starting urate-lowering therapy during an acute gout flare, a study of ...
Two factors predict early gout flare recurrence when starting urate-lowering therapy
By Michael Woodhead
14 May 2019